FKBP10 and nonpapillary renal cell carcinoma: Multiple studies have suggested that FKBP10 is highly expressed in tumor tissues and is considered as a therapeutic target for ccRCC through experimental and bioinformatics approaches, but there is a lack of further in-depth studies [21–24].